83114-201 : Xcopri Titration Pack 12.5 mg, 25 mg 12.5 mg/12.51 Oral Tablet, Film Coated
| NDC: | 83114-201 |
| Labeler: | Pci Pharma Services Canada, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Xcopri Titration Pack 12.5 mg, 25 mg |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA212839 |
| Rev. Date: | |
| CSA Schedule: | CV (US) [1] |
[1] Schedule V Controlled Substance: Low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. (i.e. Cough preparations containing not more than 200 milligrams of Codeine per 100 milliliters or per 100 grams [such as Robitussin AC, Phenergan with Codeine], and Ezogabine). More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 83114-201-14: 1 TABLET, FILM COATED IN 1 BLISTER PACK (83114‑201‑14)
Active Ingredients:
- Cenobamate
Dosage Strength:
- 12.5 mg/12.51
Pharmaceutical Classes:
- Cytochrome P450 2B6 Inducers [MoA]
- Cytochrome P450 2B6 Inhibitors [MoA]
- Cytochrome P450 2C19 Inhibitors [MoA]
- Cytochrome P450 2C8 Inducers [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Cytochrome P450 3A4 Inducers [MoA]
- GABA A Receptor Positive Modulators [MoA]
- Sodium Channel Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 83114-202 Xcopri Titration Pack 12.5 mg, 25 mg 25 mg/251 Oral Tablet, Film Coated by Pci Pharma Services Canada, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 83114-104Next: 83114-202 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.